Dawn McGuire

2.6k total citations
37 papers, 1.9k citations indexed

About

Dawn McGuire is a scholar working on Physiology, Neurology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Dawn McGuire has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Neurology and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in Dawn McGuire's work include Pain Management and Opioid Use (6 papers), Pain Mechanisms and Treatments (5 papers) and Alzheimer's disease research and treatments (5 papers). Dawn McGuire is often cited by papers focused on Pain Management and Opioid Use (6 papers), Pain Mechanisms and Treatments (5 papers) and Alzheimer's disease research and treatments (5 papers). Dawn McGuire collaborates with scholars based in United States, South Korea and Canada. Dawn McGuire's co-authors include Martha Mayo, Robert R. Luther, David Ellis, Peter S. Staats, Steven G. Charapata, Mark S. Wallace, Vandana Mathur, Michael G. Byas‐Smith, Robert B. Fisher and J. D. FELLMANN and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dawn McGuire

37 papers receiving 1.8k citations

Peers

Dawn McGuire
Freek J. Zijlstra Netherlands
Jeffrey Tobias United States
Joanna M. Ward United Kingdom
Jonathan D. Finder United States
B. Schöning Germany
Fang Xie China
Dawn McGuire
Citations per year, relative to Dawn McGuire Dawn McGuire (= 1×) peers Massimo Allegri

Countries citing papers authored by Dawn McGuire

Since Specialization
Citations

This map shows the geographic impact of Dawn McGuire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn McGuire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn McGuire more than expected).

Fields of papers citing papers by Dawn McGuire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn McGuire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn McGuire. The network helps show where Dawn McGuire may publish in the future.

Co-authorship network of co-authors of Dawn McGuire

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn McGuire. A scholar is included among the top collaborators of Dawn McGuire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn McGuire. Dawn McGuire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGuire, Dawn, et al.. (2020). Study TPX-100-5: Significant reduction in femoral bone shape change 12 months after IA TPX-100 correlates with tibiofemoral cartilage stabilization. Osteoarthritis and Cartilage. 28. S37–S38. 6 indexed citations
2.
McGuire, Dawn, N.E. Lane, Neil A. Segal, et al.. (2018). TPX-100 leads to marked, sustained improvements in subjects with knee osteoarthritis: pre-clinical rationale and results of a controlled clinical trial. Osteoarthritis and Cartilage. 26. S243–S243. 20 indexed citations
4.
Finkel, Richard S., John Day, Claudia A. Chiriboga, et al.. (2014). Results of a Phase 2 Open-Label Study of ISIS-SMNRx in Patients with Infantile (Type 1) Spinal Muscular Atrophy (S6.003). Neurology. 82(10_supplement). 8 indexed citations
5.
Fox, Edward, Daniel Wynn, Stanley Cohan, et al.. (2011). A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design. Multiple Sclerosis Journal. 18(6). 843–852. 24 indexed citations
6.
Mathur, Vandana, Jill S. Lindberg, Michael J. Germain, et al.. (2010). A Longitudinal Study of Uremic Pruritus in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 5(8). 1410–1419. 231 indexed citations
7.
Ellis, David, Sanjeeva Dissanayake, Dawn McGuire, et al.. (2008). Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study. Neuromodulation Technology at the Neural Interface. 11(1). 40–49. 40 indexed citations
8.
Silverberg, Gerald D., et al.. (2008). Continuous CSF drainage in AD. Neurology. 71(3). 202–209. 61 indexed citations
9.
Wallace, Mark S., Steven G. Charapata, Robert B. Fisher, et al.. (2006). Intrathecal Ziconotide in the Treatment of Chronic Nonmalignant Pain: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Neuromodulation Technology at the Neural Interface. 9(2). 75–86. 130 indexed citations
10.
Staats, Peter S., Thomas Yearwood, Steven G. Charapata, et al.. (2004). Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS. JAMA. 291(1). 63–63. 404 indexed citations
11.
Silverberg, Gerald D., et al.. (2004). Novel ventriculoperitoneal shunt in Alzheimer´s disease cerebrospinal fluid biomarkers. Expert Review of Neurotherapeutics. 4(1). 97–107. 12 indexed citations
12.
Royal, Walter, B. Dupont, Dawn McGuire, et al.. (2003). Topotecan in the Treatment of Acquired Immunodeficiency Syndrome-Related Progressive Multifocal Leukoencephalopathy. Journal of NeuroVirology. 9(3). 411–419. 61 indexed citations
13.
Kusdra, Leonard, Dawn McGuire, & Lynn Pulliam. (2002). Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. AIDS. 16(1). 31–38. 39 indexed citations
14.
Tumlin, James A., Lala M. Dunbar, Suzanne Oparil, et al.. (2000). Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial. Academic Emergency Medicine. 7(6). 653–662. 55 indexed citations
15.
Mathur, Vandana, Suzanne K. Swan, Lawrence J. Lambrecht, et al.. (1999). The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Critical Care Medicine. 27(9). 1832–1837. 129 indexed citations
16.
Brose, William G., et al.. (1997). Use of Intrathecal SNX-111, a Novel, N-Type, Voltage-Sensitive, Calcium Channel Blocker, in the Management of Intractable Brachial Plexus Avulsion Pain. Clinical Journal of Pain. 13(3). 256–259. 112 indexed citations
17.
Pulliam, Lynn, et al.. (1996). Monokine products as predictors of AIDS dementia. AIDS. 10(13). 1495–1500. 29 indexed citations
18.
McGuire, Dawn, Louis P. Garrison, Carmel Armon, et al.. (1996). Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. Neurology. 46(5). 1442–1442. 53 indexed citations
20.
Golby, Alexandra J., Dawn McGuire, & Lydia Bayne. (1995). Unexpected recovery from anoxic-ischemic coma. Neurology. 45(8). 1629–1630. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026